NuCana plc Gains 150.79%
NuCana plc (NCNA:NASDAQ) soared at $6.37, representing a gain of 150.8%. On Fri, Sep 13, 2024, NCNA:NASDAQ touched a New 2-Week Low of $2.54. The stock got featured on our News Catalysts scanner on Mon, Sep 16, 2024 at 09:49 AM in the 'BIOTECH' category. From Tue, Sep 03, 2024, the stock recorded 25.00% Up Days and 33.33% Green Days
The stock spiked on Mon, Aug 19, 2024 at $10.79 with a volume of 4M+.
About NuCana plc (NCNA:NASDAQ)
NuCana PLC is a clinical-stage biopharmaceutical company. It is focused on improving treatment outcomes for cancer patients by applying its ProTide technology.
Top 10 Gainers:
- Calithera Biosciences, Inc. (CALA:NASDAQ), 212.5%
- NuCana plc (NCNA:NASDAQ), 150.79%
- Kubient Inc. (KBNT:NASDAQ), 100%
- NextPlay Technologies Inc. (NXTP:NASDAQ), 76.92%
- Dermata Therapeutics Inc. (DRMA:NASDAQ), 46.84%
- REE Automotive Ltd. (REE:NASDAQ), 44.19%
- Immuneering Corporation (IMRX:NASDAQ), 42.08%
- MKDWELL Tech Inc. (MKDW:NASDAQ), 36.75%
- Coffee Holding Co., Inc. (JVA:NASDAQ), 35.94%
- Li-Cycle Holdings Corp. (LICY:NYSE), 34.21%